The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.
scientific article
Author/s
author: Paola Bonetti, Luciano Cascione, Emanuele Zucca, Francesco Bertoni, Chiara Tarantelli, Ivo Kwee, Elena Bernasconi, Anastasios Stathis, Georg Stüssi, Maurilio Ponzoni, Afua Adjeiwaa Mensah, Michela Boi, Monica Testoni, Esteban Cvitkovic
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.